Stifel analyst W. Andrew Carter reiterated a Hold rating on Tilray (NASDAQ: TLRY) after the company announced the second GMP ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE